Cord Blood Banking Leader Cryo-Cell Enters into Patent Option Agreement with Duke University
Retrieved on:
Thursday, June 11, 2020
The six-month exclusive option agreement gives Cryo-Cell an option to obtain a license to manufacture and sell products based on Dr. Joanne Kurtzbergs patents.
Key Points:
- The six-month exclusive option agreement gives Cryo-Cell an option to obtain a license to manufacture and sell products based on Dr. Joanne Kurtzbergs patents.
- Dr. Joanne Kurtzberg is an internationally renowned expert in pediatric hematology/oncology, pediatric blood and marrow transplantation, umbilical cord blood banking and transplantation, and novel applications of cord blood in the emerging fields of cellular therapies and regenerative medicine.
- More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their babys cord blood and cord tissue stem cells.
- In addition to its family bank, Cryo-Cell International has a public banking program in partnership with Duke University.